Shopping Cart
- Remove All
- Your shopping cart is currently empty
Z-LEHD-FMK is a selective and potent caspase-9 inhibitor that protects against reperfusion injury and slows apoptosis. Z-LEHD-FMK exhibits antitumor and neuroprotective activity, increases the yield of in vitro-produced preimplantation embryos of [Bubalus bubalis], and alters the cellular stress response.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $198 | In Stock | |
5 mg | $619 | In Stock | |
10 mg | $877 | In Stock | |
25 mg | $1,280 | In Stock | |
50 mg | $1,750 | In Stock |
Description | Z-LEHD-FMK is a selective and potent caspase-9 inhibitor that protects against reperfusion injury and slows apoptosis. Z-LEHD-FMK exhibits antitumor and neuroprotective activity, increases the yield of in vitro-produced preimplantation embryos of [Bubalus bubalis], and alters the cellular stress response. |
In vitro | Pretreated for 30 minutes at a concentration of 20 μM, Z-LEHD-FMK completely protects HCT116 and 293 cells from TRAIL-induced toxicity[1]. Additionally, at a concentration of 20 μM for 6 hours, Z-LEHD-FMK protects normal human hepatocytes from TRAIL-induced apoptosis[1]. |
In vivo | In spinal cord injury (SCI) rats, Z-LEHD-FMK administered intravenously at a dose of 0.8 μmol/kg for 7 days protects neurons, glia, myelin, axons, and intracellular organelles[3]. |
Molecular Weight | 690.72 |
Formula | C32H43FN6O10 |
Cas No. | 210345-04-3 |
Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90 mg/mL (130.30 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.